81
8 REFERÊNCIAS BIBLIOGRÁFICAS
1. Choo, Q.L., et al., Isolation of a cDNA clone derived from a blood-borne non-
A, non-B viral hepatitis genome. Science, 1989. 244(4902): p. 359-62.
2. Brandao, A.B., et al., [Diagnosis of hepatitis C in clinical practice: review of the
literature]. Rev Panam Salud Publica, 2001. 9(3): p. 161-8.
3. Coelho, H.S., JAS; Brandão-Mello, CE; Nabuco, LC, Hepatites. Vol. 01. 2006,
Rio de Janeiro: Editora Rúbio Ltda. 235.
4. Feldman, M., L.S. Friedman, and L.J. Brandt, eds. Sleisenger and Fordtran´s
Gastrointestinal and Liver Disease. 8 th ed. Vol. 2. 2006.
5. Reif, S., et al., Matrix metalloproteinases 2 and 9 are markers of inflammation
but not of the degree of fibrosis in chronic hepatitis C. Digestion, 2005. 71(2):
p. 124-30.
6. Heintges, T. and J.R. Wands, Hepatitis C virus: epidemiology and
transmission. Hepatology, 1997. 26(3): p. 521-6.
7. Jorge, S.G. Hepatite C. 2003 02/10/2007 [cited; Available from:
www.hepcentro.com.br.
8. Statement, N.C., EASL International Consensus Conference on Hepatitis C.
Journal of Hepatology, 1999. 30: p. 956-961.
9. Strader DB, W.T., Thomas DL, Seeff LB, Diagnosis, Manegement, and
Treatment of Hepatitis C. Hepatology 2004. 39(4): p. 1147-1171.
10. Jimenez-Hernandez, N., et al., Epidemic dynamics of two coexisting hepatitis
C virus subtypes. J Gen Virol, 2007. 88(Pt 1): p. 123-33.
11. Pradat, P., et al., Predictive value of ALT levels for histologic findings in
chronic hepatitis C: a European collaborative study. Hepatology, 2002. 36(4 Pt
1): p. 973-7.
12. Puoti, C., et al., Clinical, histological, and virological features of hepatitis C
virus carriers with persistently normal or abnormal alanine transaminase
levels. Hepatology, 1997. 26(6): p. 1393-8.
13. Villela-Nogueira, C.A., et al., Gamma-glutamyl transferase (GGT) as an
independent predictive factor of sustained virologic response in patients with
hepatitis C treated with interferon-alpha and ribavirin. J Clin Gastroenterol,
2005. 39(8): p. 728-30.
14. Strassburg, C.P. and M.P. Manns, Approaches to liver biopsy techniques--
revisited. Semin Liver Dis, 2006. 26(4): p. 318-27.
15. Forns, X., et al., Identification of chronic hepatitis C patients without hepatic
fibrosis by a simple predictive model. Hepatology, 2002. 36(4 Pt 1): p. 986-92.
16. Halfon, P., et al., [Serum markers of non-invasive fibrosis in chronic hepatitis C
virus infection]. Rev Med Interne, 2006. 27(10): p. 751-61.
17. Afdhal, N.H. and D. Nunes, Evaluation of liver fibrosis: a concise review. Am J
Gastroenterol, 2004. 99(6): p. 1160-74.
18. Mallat, A. and D. Dhumeaux, [Assessment of hepatic fibrosis: what is the role
of non-invasive markers in 2003?]. Gastroenterol Clin Biol, 2003. 27(4): p.
367-70.
19. Oberti, F., et al., Noninvasive diagnosis of hepatic fibrosis or cirrhosis.
Gastroenterology, 1997. 113(5): p. 1609-16.
20. Colloredo, G., et al., Impact of liver biopsy size on histological evaluation of
chronic viral hepatitis: the smaller the sample, the milder the disease. J
Hepatol, 2003. 39(2): p. 239-44.